Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma

Table 1 Clinicopathological features according to neutrophil-lymphocyte ratio n (%)

Variable	NLR
	Cases	≤3.0	> 3.0	P value1
Age (yr)				0.112
≤ 57.02	201 (54.2)	167 (83.1)	34 (16.9)
> 57.0	170 (45.8)	130 (76.5)	40 (23.5)
Sex				0.562
Female	95 (25.6)	78 (82.1)	17 (17.9)
Male	276 (74.4)	219 (79.3)	57 (20.7)
Location				0.372
Upper	23 (6.2)	19 (82.6)	4 (17.4)
Middle	256 (69.0)	200 (78.1)	56 (21.9)
Lower	92 (24.8)	78 (84.8)	14 (15.2)
Differentiation				0.487
Well	58 (15.6)	46 (79.3)	12 (20.7)
Moderate	245 (66.0)	193 (78.8)	52 (21.2)
Poor	68 (18.3)	58 (85.3)	10 (14.7)
pT status				0.007
T1	17 (4.6)	15 (88.2)	2 (11.8)
T2	88 (23.7)	80 (90.9)	8 (9.1)
T3	266 (71.7)	202 (75.9)	64 (24.1)
pN status				0.592
N0	199 (53.6)	163 (81.9)	36 (18.1)
N1	102 (27.5)	82 (80.4)	20 (19.6)
N2	55 (14.8)	41 (74.5)	14 (25.5)
N3	15 (4.0)	11 (73.3)	4 (26.7)
Stage				0.566
IB	20 (5.4)	17 (85.0)	3 (15.0)
IIA	58 (15.6)	50 (86.2)	8 (13.8)
IIB	148 (39.9)	119 (80.4)	29 (19.6)
IIIA	83 (22.4)	66 (79.5)	17 (20.5)
IIIB	47 (12.7)	34 (72.3)	13 (27.7)
IIIC	15 (4.0)	11 (73.3)	4 (26.7)
Total	371 (100)	297 (80.1)	74 (19.9)

¹χ² test;

²Median age. NLR: Neutrophil-lymphocyte ratio; pN: Pathologic node; pT: Pathologic tumor.